Bạn đang xem bản rút gọn của tài liệu. Xem và tải ngay bản đầy đủ của tài liệu tại đây (1.13 MB, 22 trang )
<span class="text_page_counter">Trang 2</span><div class="page_container" data-page="2">
<small>•</small> Detect emerging pathogen, reappearance of an old one, or outbreaks.
<small>•</small> Monitor behavior of existing pathogens
<small>•</small> Monitor trends in epidemiology: risk factors, age groups, seasonality, etc.
<small>•</small> Measure disease burden: absolute (incidence) or relative to other diseases
<small>•</small> Evaluate impact of an intervention
<small>•</small> It’s helpful to actually write down the objectives
<small>19-23 June 2017 FETP Vietnam | Cohorts 7 & 8 Surveillance Module 2 </small>
</div><span class="text_page_counter">Trang 3</span><div class="page_container" data-page="3"><small>•</small>
<small>•</small>
<small>•</small>
<small> Will it be more than one? based on syndromic Surveillance and/or laboratory testing? </small>
<small>•</small>
<small>•</small>
<small>•</small>
Decide first, what the major public health questions are.
With a limited sentinel system, can also get risk factor data such as age, medical conditions, vaccination status, etc.
<small>•</small>
<small>•</small>
<small>•</small>
<small>•</small>
<small>19-23 June 2017 FETP Vietnam | Cohorts 7 & 8 Surveillance Module 4 </small>
</div><span class="text_page_counter">Trang 5</span><div class="page_container" data-page="5"><small>•</small>
Laws <small>•</small>
Ministry of Health
Medical community <small>•</small>
Funding
Staff
Training
</div><span class="text_page_counter">Trang 6</span><div class="page_container" data-page="6"><small>19-23 June 2017 FETP Vietnam | Cohorts 7 & 8 Surveillance Module 6 </small>
<small>•Data: </small>
<small> Source content </small>
</div><span class="text_page_counter">Trang 8</span><div class="page_container" data-page="8"><small>•</small>
Decide how it will be used, what decisions will be based on the data.
Limit the amount of data to what is actually going to be useful.
<small>•</small>
Case definitions
<small>•</small>
<small>•Standardization helps compare apples to apples •Can have different levels of certainty: </small>
<small> Confirmed, probable, suspect </small>
<small> Surveillance case definition may differ from clinical diagnostic definitions: </small>
<i><small>e.g. ILI </small></i>
<small>•Components: diagnostic criteria (lab and clinical); who, where, when Is laboratory confirmation required? </small>
<b><small> Who</small></b><i><small>: is there an age group of interest? E.g. the pediatric influenza mortality </small></i>
<i><small>surveillance system. If all age groups, how do you aggregate? </small></i>
<b><small> Where</small></b><small>: may be especially important for disease burden estimates when a specific catchment area is under surveillance. </small>
<b><small> When</small></b><i><small>: some systems may run seasonally, e.g. influenza. </small></i>
<small>19-23 June 2017 FETP Vietnam | Cohorts 7 & 8 Surveillance Module 10 </small>
</div><span class="text_page_counter">Trang 11</span><div class="page_container" data-page="11"><small>•</small> Influenza-like Illness:
An acute respiratory infection with:
<small>measured fever of ≥ 38 C°; and cough; </small>
<small>with onset within the last 10 days. </small>
<small>•</small> Severe acute respiratory infections (SARI)
An acute respiratory infection with:
<small>history of fever or measured fever of ≥ 38 C°; and cough; </small>
<small>with onset within the last 10 days; and requires hospitalization </small>
</div><span class="text_page_counter">Trang 12</span><div class="page_container" data-page="12"><small>19-23 June 2017 FETP Vietnam | Cohorts 7 & 8 Surveillance Module 12 </small>
</div><span class="text_page_counter">Trang 13</span><div class="page_container" data-page="13"><small>•Representativeness: what population needs monitoring? (consider HIV vs. Influenza) </small>
<small> General hospitals may be better than referral centers for some diseases but not others Consider variations in climate, ethnicity, risk factors. </small>
<small>•Logistics: </small>
<small> Need to be able to transmit data and clinical specimens </small>
<small>•Patient volume: </small>
<small> Site should get sufficient number of cases to be meaningful. </small>
<small>•Ability to determine denominator: </small>
<small> Can you estimate the proportion of total cases that are actually reported/tested? Can you estimate the size of the catchment population? </small>
</div><span class="text_page_counter">Trang 14</span><div class="page_container" data-page="14"><small>•</small> Number of sites depends somewhat on variety of disease ecology
<small> Are there differences in climate? </small>
<small> Is there much diversity in the population? </small>
<small> Is there a region or population of special interest? </small>
<small>•</small> How many can you afford?
<small>•</small> What portion of total numbers reported are likely to be truly the disease of interest?
<small>•</small> Number of specimens/cases is not related to population size but rather prevalence of the disease.
<small>19-23 June 2017 FETP Vietnam | Cohorts 7 & 8 Surveillance Module 14 </small>
</div><span class="text_page_counter">Trang 15</span><div class="page_container" data-page="15"><small>Italy </small>
<small>Rwanda </small>
<small>Albania </small>
</div><span class="text_page_counter">Trang 16</span><div class="page_container" data-page="16"><small>•</small> Lab based or clinic/hospital
<small>•</small> Mechanism to report: electronic, web, telephone, mail
Technology is not the answer. Get the system working first!
<small>•</small> Immediate reporting of priority diseases:
<small>•</small> Lowest level that reports
<small>19-23 June 2017 FETP Vietnam | Cohorts 7 & 8 Surveillance Module 16 </small>
</div><span class="text_page_counter">Trang 18</span><div class="page_container" data-page="18"><small>19-23 June 2017 FETP Vietnam | Cohorts 7 & 8 Surveillance Module 18 </small>
</div><span class="text_page_counter">Trang 19</span><div class="page_container" data-page="19"><small>•</small> Laboratory reports and data summaries back to reporting facility
<small>•</small> IHR secure channels
<small>•</small> Meetings and conferences
</div><span class="text_page_counter">Trang 20</span><div class="page_container" data-page="20"><small>•</small> Basic indicators should monitor timeliness, completeness, and validity of data
However indicators don’t tell the whole story
<small>•</small> Watch for aberrations in the data
Don’t assume you know the reason
<small>•</small> Keep system small enough that monitoring can assure the quality of the data
<small>•</small> Periodic audits important to really dig deep
<small>19-23 June 2017 FETP Vietnam | Cohorts 7 & 8 Surveillance Module 20 </small>
</div><span class="text_page_counter">Trang 21</span><div class="page_container" data-page="21"><small>•</small> Consistency in reporting is critical since the goal is to observe trends
<small> All must report the same thing All must report regularly </small>
<small>•</small> Don’t get ambitious – a little data goes a long way towards understanding a problem
<small> Aim for representativeness rather than volume </small>
</div><span class="text_page_counter">Trang 22</span><div class="page_container" data-page="22">